dental adhesive News
-
RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive biomaterial. Dr. Michael R. Norton, ...
By RevBio Inc.
-
CSIRO grants global license for new polymer technology
Reversible Addition-Fragmentation chain Transfer (or RAFT) technology is an elegant and powerful polymerisation process that has given rise to a new branch of polymer chemistry. RAFT enables the development of very complex molecules that can be used for a wide range of products. The technology is already generating major improvements in the areas of coatings and paints, electroactive materials, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you